Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@genomics-online.com

Human KAAG1 CRISPR gRNA + Cas9 in Lenti Particles

gRNA + Cas9 PExp, GEEN Lentiviral Vector pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro Ampicillin U6 Promoter unconjugated Stable
Catalog No. ABIN5257803

Quick Overview for Human KAAG1 CRISPR gRNA + Cas9 in Lenti Particles (ABIN5257803)

Gene

KAAG1 (Kidney Associated Antigen 1 (KAAG1))

Application

Protein Expression (PExp), Genome Editing with Engineered Nucleases (GEEN)

Insert

gRNA + Cas9

Vector

Lentiviral Vector

Vector Backbone

pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro

Promoter

U6 Promoter, SFFV Promoter

Bacterial Resistance

Ampicillin

Expression Type

Stable, Transient
  • Species

    Human

    Purpose

    Individual gRNA against KAAG1 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (sgRNA and Cas9 in a single vector)

    Sequence

    Sequence available upon placing order

    Specificity

    GRNAs are designed for use with Cas9 Nuclease only.
    Cas9 Nuclease is under the control of the SFFV promoter which should work for a vast majority of cells, except ES cells or iPS cells.

    Components

    Lentiviral particles with an individual gRNA (300 μL) for a specific sequence of KAAG1

    Selectable Marker

    Puromycin

    Sequencing Primer

    U6 Forward Primer: 5'--TACGTCCAAGGTCGGGCAGGAAGA--3'
  • Application Notes

    Recommended for quality control: Restriction Enzyme Digest and Sequencing

    Restrictions

    For Research Use only
  • Format

    Viral Particles

    Storage

    -80 °C

    Expiry Date

    12 months
  • Target

    KAAG1 (Kidney Associated Antigen 1 (KAAG1))

    Alternative Name

    KAAG1

    NCBI Accession

    NM_181337
You are here: